WHO/BS/2022.2420: Report on the collaborative study to establish the 1st WHO International Standard for anti-β2GPI Immunoglobulin G in human serum

Overview

This document has been prepared for the purpose of inviting comments and suggestions on the proposals contained therein, which will then be considered by the Expert Committee on Biological Standardization (ECBS). Comments MUST be received by 28 March 2022 and should be addressed to the attention: World Health Organization, 1211 Geneva 27, Switzerland, attention: Technical Standards and Specifications (TSS). Comments may also be submitted electronically to the Responsible Officer: Dr Ivana Knezevic at email: knezevici@who.int.